Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery plus intraperitoneal hyperthermic chemotherapy in platinum-resistant recurrent ovarian cancer (Phase II)
2005-000929-31Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Mar 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxorubicin in ovarian cancer, sponsored by Policlinico Gemelli. Started Mar 2007; status: completed.
02
Drugs
doxorubicin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2005-000929-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000929-31.